This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated services to various U.S. government agencies. This contract does not have a set-aside designation. Oxford Nanopore Technologies also holds several federal contract Indefinite Delivery Vehicles (IDVs) with the Defense Health Agency, USDA Agricultural Research Service, and Air Force Life Cycle Management Center to facilitate efficient procurement of its sequencing products and services across government research initiatives.
Generated 8/7/24, 9:22 AM